SCHEMBL13859482

SCHEMBL13859482

COc1ccc(CC=O)c(F)c1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 3/20 0.38
ALDH1A1 P00352 8/20 0.38
MAPT P10636 5/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
PRKDC P78527 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 4/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18894093 0.82 ALDH1A1 (0.33) TDP1POLBALDH1A1MAPTALOX15
SCHEMBL587048 0.79 ALDH1A1 (0.46) TDP1KDM4EPOLBCTDSP1L3MBTL1
SCHEMBL5495434 0.79 ALDH1A1 (0.38) KDM4EPOLBL3MBTL1MEN1KMT2A
SCHEMBL5165930 0.79 ALDH1A1 (0.40) KDM4EPOLBCTDSP1MEN1KMT2A
SCHEMBL577619 0.78 ALDH1A1 (0.37) KDM4EPOLBL3MBTL1MEN1KMT2A
SCHEMBL25388605 0.75 ALDH1A1 (0.38) POLBMEN1KMT2AHTTALDH1A1
SCHEMBL4617532 0.75 TDP1 (0.55) TDP1POLBL3MBTL1MEN1KMT2A
SCHEMBL1531294 0.75 HTT (0.57) TDP1MEN1KMT2AHTTALDH1A1
SCHEMBL16794991 0.73 HTR2A (0.45) L3MBTL1KMT2AALDH1A1SMN1; SMN2
SCHEMBL1179747 0.73 TDP1 (0.62) TDP1KDM4EPOLBCTDSP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO disclosed